Daily Caller patriots exclusive content
Analysis

How America’s Most Elite Consulting Firm Coached Purdue Pharma To Sell More Opioids

(Photo by Spencer Platt/Getty Images)

Anders Hagstrom White House Correspondent
Font Size:

McKinsey is nearing a settlement deal with several state attorneys general for its role advising a major pharmaceutical company “turbocharge” its sale of OxyCotin in the middle of the opioid crisis, The Wall Street Journal (WSJ) reported Tuesday.

Negotiations over the potential settlement are ongoing, but the final number could see McKinsey owing hundreds of millions of dollars, according to WSJ. McKinsey made a rare statement in December acknowledging wrongdoing but stopping short of an apology for its role. The company had recommended in 2017 that Purdue offer rebates to OxyCotin manufacturers based on how many of their customers overdosed.